Physiology and histology of white blood cells and platelets - Wk 1-2
... After a vascular injury, platelets encounter collagen, proteoglycans, fibronectin and other adhesive glycoproteins all found in the extracellular matrix (ECM), beneath the endothelium. Once they encounter the ECM, platelets undergo 3 reactions: ...
... After a vascular injury, platelets encounter collagen, proteoglycans, fibronectin and other adhesive glycoproteins all found in the extracellular matrix (ECM), beneath the endothelium. Once they encounter the ECM, platelets undergo 3 reactions: ...
Thrombosis Target: Manipulating Platelet Aggregation
... prone to various diseases ranging from stroke to heart disease ...
... prone to various diseases ranging from stroke to heart disease ...
"Multiscale Patient-Specific Systems Biology" Scott L. Diamond, PhD
... Professor and Chair, Department of Chemical and Biomolecular Engineering Institute for Medicine and Engineering University of Pennsylvania Predicting tissue function based upon an individual’s unique cells requires a multiscale Systems Biology approach to understand the coupling of intracellular sig ...
... Professor and Chair, Department of Chemical and Biomolecular Engineering Institute for Medicine and Engineering University of Pennsylvania Predicting tissue function based upon an individual’s unique cells requires a multiscale Systems Biology approach to understand the coupling of intracellular sig ...
Rare Bleeding Disorders
... • Clotting factor deficiencies (I, II, V, combined V & VIII, VII, X, XI, XIII) • Platelet function disorders (e.g. Glanzmann Thrombasthenia, Bernard-Soulier Syndrome) • Increase in identified number of people with rare clotting factor deficiencies or platelet function disorders (WFH) ...
... • Clotting factor deficiencies (I, II, V, combined V & VIII, VII, X, XI, XIII) • Platelet function disorders (e.g. Glanzmann Thrombasthenia, Bernard-Soulier Syndrome) • Increase in identified number of people with rare clotting factor deficiencies or platelet function disorders (WFH) ...
FO R IMMEDIAT E RELEASE Harness The Power in
... A-PRP stands for autologous platelet rich plasma. Autologous means “harnessed” from one’s own body. APRP is a biological solution from the patient’s whole blood that contains concentrated growth factors, high levels of platelet concentration, and proteins. Platelets are the architects of tissue heal ...
... A-PRP stands for autologous platelet rich plasma. Autologous means “harnessed” from one’s own body. APRP is a biological solution from the patient’s whole blood that contains concentrated growth factors, high levels of platelet concentration, and proteins. Platelets are the architects of tissue heal ...
Platelet
Platelets, also called thrombocytes, are a component of blood whose function (along with the coagulation factors) is to stop bleeding by clumping and clogging blood vessel injuries. Platelets have no cell nucleus: they are fragments of cytoplasm which are derived from the megakaryocytes of the bone marrow, and then enter the circulation. These unactivated platelets are biconvex discoid (lens-shaped) structures, 2–3 µm in greatest diameter. Platelets are found only in mammals, whereas in other animals (e.g. birds, amphibians) thrombocytes circulate as intact mononuclear cells.On a stained blood smear, platelets appear as dark purple spots, about 20% the diameter of red blood cells. The smear is used to examine platelets for size, shape, qualitative number, and clumping. The ratio of platelets to red blood cells in a healthy adult is 1:10 to 1:20. The main function of platelets is to contribute to hemostasis: the process of stopping bleeding at the site of interrupted endothelium. They gather at the site and unless the interruption is physically too large, they plug the hole. First, platelets attach to substances outside the interrupted endothelium: adhesion. Second, they change shape, turn on receptors and secrete chemical messengers: activation. Third, they connect to each other through receptor bridges: aggregation. Formation of this platelet plug (primary hemostasis) is associated with activation of the coagulation cascade with resultant fibrin deposition and linking (secondary hemostasis). These processes may overlap: the spectrum is from a predominantly platelet plug, or ""white clot"" to a predominantly fibrin clot, or ""red clot"" or the more typical mixture. The final result is the clot. Some would add the subsequent clot retraction and platelet inhibition as fourth and fifth steps to the completion of the process and still others a sixth step wound repair.Low platelet concentration is thrombocytopenia and is due to either decreased production or increased destruction. Elevated platelet concentration is thrombocytosis and is either congenital, reactive (to cytokines), or due to unregulated production: one of the myeloprolerative neoplasms or certain other myeloid neoplasms. A disorder of platelet function is a thrombocytopathy.Normal platelets can respond to an abnormality on the vessel wall rather than to hemorrhage, resulting in inappropriate platelet adhesion/activation and thrombosis: the formation of a clot within an intact vessel. These arise by different mechanisms than a normal clot. Examples are: extending the fibrin clot of venous thrombosis; extending an unstable or ruptured arterial plaque, causing arterial thrombosis; and microcirculatory thrombosis. An arterial thrombus may partially obstruct blood flow, causing downstream ischemia; or completely obstruct it, causing downstream tissue death.